In a filing, Eliem Therapeutics Inc revealed its EVP, R&D AND CSO Morisset Valerie unloaded Company’s shares for reported $0.55 million on Jul 22 ’24. In the deal valued at $8.03 per share,69,005 shares were sold. As a result of this transaction, Morisset Valerie now holds 31,317 shares worth roughly $0.19 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Morisset Valerie sold 60,201 shares, generating $434,325 in total proceeds. Upon selling the shares at $7.21, the EVP, R&D AND CSO now owns 100,322 shares.
Before that, Morisset Valerie sold 38,576 shares. Eliem Therapeutics Inc shares valued at $267,332 were divested by the EVP, R&D AND CSO at a price of $6.93 per share. As a result of the transaction, Morisset Valerie now holds 160,523 shares, worth roughly $1.0 million.
Price Performance Review of ELYM
On Tuesday, Eliem Therapeutics Inc [NASDAQ:ELYM] saw its stock jump 3.84% to $6.22. Over the last five days, the stock has lost -13.13%. Eliem Therapeutics Inc shares have risen nearly 130.37% since the year began. Nevertheless, the stocks have risen 129.52% over the past one year. While a 52-week high of $11.55 was reached on 05/03/24, a 52-week low of $2.35 was recorded on 04/05/24. SMA at 50 days reached $7.62, while 200 days put it at $4.65.
Levels Of Support And Resistance For ELYM Stock
The 24-hour chart illustrates a support level at 5.97, which if violated will result in even more drops to 5.73. On the upside, there is a resistance level at 6.39. A further resistance level may holdings at 6.57. The Relative Strength Index (RSI) on the 14-day chart is 38.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.92%. Stochastics%K at 16.60% indicates the stock is a buying.
How much short interest is there in Eliem Therapeutics Inc?
A steep rise in short interest was recorded in Eliem Therapeutics Inc stocks on
